← Back
$SRPT All transactions

Sarepta Therapeutics, Inc.

A

$ Value

$0

Shares

50,000

Price

$0

Filed

Sep 5

Insider

Name

Rodino-Klapac Louise

Title

President, R&D and Tech Ops

CIK

0001836218

Roles

Officer

Transaction Details

Transaction Date

2025-09-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

228,612

Footnotes

The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company. | Includes 106 shares of common stock purchased on August 31, 2025 through the Company's Employee Stock Purchase Plan | The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.

Filing Info

Accession No.

0001193125-25-197425

Form Type

4

Issuer CIK

0000873303

Rodino-Klapac Louise's History

Date Ticker Type Value
2025-11-17 SRPT F $84K
2025-09-03 SRPT A $0
2025-09-03 SRPT A $0
2025-08-05 SRPT A $0

Other Insiders at SRPT (90d)

No other insider activity at this issuer in the last 90 days.